{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:07:30Z","timestamp":1791310050180,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd001392.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T00:00:00Z","timestamp":1439424000000}}],"reference-count":321,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T00:00:00Z","timestamp":1439424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T00:00:00Z","timestamp":1439424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001392.pub3","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T17:09:14Z","timestamp":1439485754000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults"],"prefix":"10.1002","volume":"2017","author":[{"given":"Khin","family":"Hnin","sequence":"first","affiliation":[{"name":"Flinders University; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Queen Elizabeth Hospital; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin V","family":"Carson-Chahhoud","sequence":"additional","affiliation":[{"name":"The University of Adelaide; School of Medicine; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Evans","sequence":"additional","affiliation":[{"name":"Hemel Hempstead Hospital; Thoracic Medicine; Hillfield Road Hemel Hempstead Herts UK HP2 4AD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Greenstone","sequence":"additional","affiliation":[{"name":"Castle Hill Hospital; Cottingham North Humberside UK HU16 5JQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J","family":"Smith","sequence":"additional","affiliation":[{"name":"The Queen Elizabeth Hospital, Central Adelaide Local Health Network; Respiratory Medicine Unit; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,8,13]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD001392.pub3-BIB0002|cit1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis","volume":"209","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0001|cit2","unstructured":"Altenburg J de Graaff C van der Werf T Boersma W Long-term azithromycin treatment: a randomised placebo-controlled trial in non-CF bronchiectasis; results from the BAT trial European Respiratory Society 21st Annual Congress; 2011 Sep 24-28; Amsterdam 2011"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0003|cit3","first-page":"A3658","article-title":"Evaluation of symptoms score and QOL in azithromycin maintenance treatment: results of a RCT trial in patients with bronchiectasis","volume":"185","author":"Boersma","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD001392.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","article-title":"Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis","volume":"162","author":"Barker","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"114S","DOI":"10.1378\/chest.120.3_suppl.114S","article-title":"Treatment with tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa","volume":"120","author":"Couch","year":"2001","journal-title":"Chest"},{"issue":"Suppl 31","key":"10.1002\/14651858.CD001392.pub3-BIB0006|cit6","first-page":"494s","article-title":"The relationship between antimicrobial efficacy and improved medical condition in tobramycin solution for inhalation therapy in bronchiectasis","volume":"16","author":"Fiel","year":"2000","journal-title":"European Respiratoy Journal"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001392.pub3-BIB0007|cit7","first-page":"A68","article-title":"Tobramycin solution for inhalation (TOBI) as maintenance treatment for bronchiectasis patients with Pseudomonas aeruginosa","volume":"54","author":"O'Donnell","year":"1999","journal-title":"Thorax"},{"issue":"Suppl 16","key":"10.1002\/14651858.CD001392.pub3-BIB0008|cit8","first-page":"79P","article-title":"Double blind randomised placebo controlled study of long term high dose antibiotic in patients with bronchiectasis","volume":"72","author":"Currie","year":"1987","journal-title":"Clinical Research"},{"issue":"280","key":"10.1002\/14651858.CD001392.pub3-BIB0009|cit9","first-page":"799","article-title":"Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis","volume":"76","author":"Currie","year":"1990","journal-title":"Quarterly Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200504020-00005","article-title":"The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis","volume":"4","author":"Cymbala","year":"2005","journal-title":"Treatments in Respiratory Medicine"},{"issue":"7","key":"10.1002\/14651858.CD001392.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/resp.12130","article-title":"Effects of long-term azithromycin therapy on airway oxidative","volume":"18","author":"Diego","year":"2013","journal-title":"Respirology (Carlton, Vic.)"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1345\/aph.1E099","article-title":"Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa","volume":"39","author":"Drobnic","year":"2005","journal-title":"Annals of Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD001392.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1183\/09031936.97.10050994","article-title":"Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study","volume":"10","author":"Koh","year":"1997","journal-title":"European Respiratory Journal"},{"issue":"11","key":"10.1002\/14651858.CD001392.pub3-BIB0014|cit14","first-page":"824","article-title":"[Impact of treatment with low dose roxithromycin on stable bronchiectasis]","volume":"35","author":"Liu","year":"2012","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi [Chinese Journal of Tuberculosis and Respiratory Diseases]"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/resp.12233","article-title":"Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis","volume":"19","author":"Wu","year":"2014","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/bmj.2.5039.255","article-title":"Prolonged antibiotic treatment of severe bronchiectasis: a report by a subcommittee of the Antibiotics Clinical Trials (Non-Tuberculous) Committee of the Medical Research Council","volume":"2","author":"Medical Research Council","year":"1957","journal-title":"British Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD001392.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1517\/14656566.2011.563735","article-title":"Inhaled gentamicin in non-cystic fibrosis bronchiectasis: effects of long-term therapy","volume":"12","author":"Antoniu","year":"2011","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201005-0756OC","article-title":"A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis","volume":"183","author":"Murray","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD001392.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0954-6111(99)90090-2","article-title":"Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa","volume":"93","author":"Orriols","year":"1999","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0020|cit20","unstructured":"Chen AC-H Martin MM Burr L Hasnain SZ Lourie R Bowler SD Clinical benefits of long-term, low-dose erythromycin in bronchiectasis are not due to anti-inflammatory effects American Thoracic Society International Conference; 2013 May 17-22; Philadelphia 2013"},{"issue":"12","key":"10.1002\/14651858.CD001392.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0022|cit22","first-page":"A6862","article-title":"The Bronchiectasis and Low-dose Erythromycin Study (BLESS)","volume":"185","author":"Serisier","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0023|cit23","first-page":"946","article-title":"Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations","volume":"105(6)","author":"Serisier","year":"2011","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0024|cit24","unstructured":"Bruinenberg P Serisier D Blanchard J Cipolla D Gonda I Effects and modulation of release rate of inhaled ciprofloxacin with liposomal formulations in healthy subjects and patients with bronchiectasis European Respiratory Society 20th Annual Congress; 2010 Sep 18-22; Barcelona 2010"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0025|cit25","unstructured":"Cipolla DC Gonda I Serisier D Bruinenberg P Dual release ciprofloxacin for inhalation (DRCFI) improves time to first exacerbation in bronchiectasis Journal of Aerosol Medicine and Pulmonary Drug Delivery 2011 A27"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Serisier D Kolbe J Greville H Gonda I Bruinenberg P Inhaled liposomal ciprofloxacin significantly reduces sputum Pseudomonas aeruginosa density and increases time to first exacerbation in a 168 day placebo controlled study in non-cystic fibrosis bronchiectasis American Thoracic Society International Conference; 2011 May 13-18; Denver Denver, Colorado 2011 A4866","DOI":"10.1164\/ajrccm-conference.2011.183.1_MeetingAbstracts.A4866"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/thoraxjnl-2013-203207","article-title":"Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial","volume":"68","author":"Serisier","year":"2013","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0028|cit28","unstructured":"Serisier DJ Thompson PJ Greville H Kolbe J Bruinenberg PR Dual release ciprofloxacin for inhalation (DRCFI) reduces sputum Pseudomonas aeruginosa (Pa) density and delays time to infective pulmonary exacerbation in non-cystic fibrosis (CF) bronchiectasis (BE) American Thoracic Society International Conference; 2011 May 13-18; Denver 2011 334s [1928]"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.99.13236199","article-title":"A pilot study of low-dose erythromycin in bronchiectasis","volume":"13","author":"Tsang","year":"1999","journal-title":"European Respiratory Journal"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001392.pub3-BIB0030|cit30","first-page":"A174","article-title":"Erythromycin reduces sputum volume and improves lung functions in bronchiectasis","volume":"157","author":"Tsang","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD001392.pub3-BIB0031|cit31","first-page":"TP","article-title":"Improving enrolment and retention of Maori and Pacifica families in respiratory research","volume":"16","author":"Mobberley","year":"2011","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","article-title":"Long-term azithromycin for indigenous children with non-cystic fibrosis bronchiectasis or chronic suppuratives lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"Valery","year":"2013","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2431-12-122","article-title":"Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomised controlled trial","volume":"12","author":"Valery","year":"2012","journal-title":"BMC Pediatrics"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0034|cit34","unstructured":"Alder J Wilson R Welte T Polverino E De Soyza A Greville H Antimicrobial efficacy of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis European Respiratory Society 21st Annual Congress; 2011 Sep 24-28; Amsterdam 2011"},{"issue":"5","key":"10.1002\/14651858.CD001392.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1517\/13543784.2013.783565","article-title":"Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a Phase II randomized study","volume":"22","author":"Antoniu","year":"2013","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"5","key":"10.1002\/14651858.CD001392.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1183\/09031936.00071312","article-title":"Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study","volume":"41","author":"Wilson","year":"2013","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0037|cit37","first-page":"A6407","article-title":"Randomized, placebo-controlled, double-blind, multi-center study to evaluate the safety and efficacy of ciprofloxacin dry powder for inhalation (ciprofloxacin DPI) compared with placebo In patients with non-cystic fibrosis bronchiectasis","volume":"183","author":"Wilson","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0038|cit38","first-page":"35","article-title":"Azithromycin decreases exacerbations in non-cystic fibrosis bronchiectasis","volume":"17","author":"Jayaran","year":"2012","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbation in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0040|cit40","first-page":"A3657","article-title":"Azithromycin decreases exacerbations in non-cystic fibrosis bronchiectasis","volume":"185","author":"Wong","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2710.2006.00708.x","article-title":"Effects of clarithromycin on inflammatory parameters and clinical conditions in children with bronchiectasis","volume":"31","author":"Yalcin","year":"2006","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0042|cit42","first-page":"660","article-title":"Preclinical and clinical studies on TE-031(A-56268) in elderly subjects","volume":"36","author":"Adachi","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001392.pub3-BIB0043|cit43","first-page":"569","article-title":"Basic and clinical studies on TE-031 (A-56268). [Japanese]","volume":"36","author":"Takeda","year":"1988","journal-title":"Chemotherapy"},{"issue":"53","key":"10.1002\/14651858.CD001392.pub3-BIB0044|cit44","first-page":"2995","article-title":"[Studies of the clinical and respiratory functional effects of a mucolytic-antibiotic preparation in chronic bronchopulmonary diseases. Controlled double-blind single code studies]. [Italian]","volume":"59","author":"Alberto","year":"1968","journal-title":"Minerva Medica"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0045|cit45","first-page":"44","article-title":"[Direct current in the overall treatment of inflammatory suppurative diseases of the lungs]. [Article in Russian]","volume":"2","author":"Alekseenko","year":"1978","journal-title":"Voprosy Kurortologii, Fizioterapii, i Lechebonoi Fizicheskoi Kultury"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"56P","DOI":"10.1042\/cs074056Pa","article-title":"Amoxycillin with and without probenecid in the management of patients with bronchiectasis","volume":"74(Suppl 18)","author":"Allen","year":"1988","journal-title":"Clinical Science"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0954-6111(08)80018-2","article-title":"The use of probenecid to increase the serum amoxycillin levels in patients with bronchiectasis","volume":"84","author":"Allen","year":"1990","journal-title":"Respiratory Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001392.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5144\/0256-4947.1998.469","article-title":"Pseudomonas aeruginosa in hospitalized patients with infective exacerbations of bronchiectasis: clinical and research implications","volume":"18","author":"Al Mobeireek","year":"1998","journal-title":"Annals of Saudi Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0049|cit49","first-page":"7","article-title":"A comparative study between papase with tetracycline and tetracycline plain in the treatment of respiratory tract infections","volume":"7","author":"Alora","year":"1978","journal-title":"Philippine Journal of Microbiology and Infectious Diseases"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.rmed.2008.06.005","article-title":"Effects of long-term low-dose azithromycin inpatients with non-CF bronchiectasis","volume":"102","author":"Anwar","year":"2008","journal-title":"Respiratory Medicine"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0051|cit51","first-page":"808","article-title":"Antibiotic therapy in infections of the respiratory tract","volume":"90","author":"Barach","year":"1952","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2125.2000.00105.x","article-title":"The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing","volume":"49","author":"Begg","year":"2000","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD001392.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000238099","article-title":"Study of the diffusion of cefotiam in the bronchial secretions","volume":"28","author":"Bergogne Berezin","year":"1982","journal-title":"Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD001392.pub3-BIB0054|cit54","first-page":"341","article-title":"Influence of a fluidifying agent (bromhexine) on the penetration of antibiotics into respiratory secretions","volume":"5","author":"Bergogne Berezin","year":"1985","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"10","key":"10.1002\/14651858.CD001392.pub3-BIB0055|cit55","first-page":"466","article-title":"[Comparative study of the clinical activity of tetracycline and a combination of tetracycline and thiamphenicol in respiratory tract infections. Controlled study of a cooperative type]. [Italian]","volume":"64","author":"Bevilacqua","year":"1973","journal-title":"Minerva Medica"},{"issue":"5","key":"10.1002\/14651858.CD001392.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.130.5.1503","article-title":"Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis","volume":"130","author":"Bilton","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1378\/chest.12-1763","article-title":"Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis","volume":"144","author":"Bilton","year":"2013","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"A49 [S106]","DOI":"10.1136\/thoraxjnl-2011-201054b.106","article-title":"A randomised double blind 13 week crossover trial of hypertonic saline(HTS) (6%) vs isotonic saline (ITS) (0.9%) in patients with bronchiectasis","volume":"66","author":"Bradley","year":"2011","journal-title":"Thorax"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF01967062","article-title":"Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections","volume":"11","author":"Brambilla","year":"1992","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0060|cit60","first-page":"483","article-title":"Prophylactic administration of Bactrim in chronic bronchitis: a double blind clinical and biological study","volume":"64","author":"Bruninx","year":"1973","journal-title":"Acta Tuberculosea et Pneumologica Belgica"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0061|cit61","first-page":"483","article-title":"Prophylactic administration of Bactrim in chronic bronchitis. A double blind clinical and biological study (author's transl)","volume":"64","author":"Brunix","year":"1974","journal-title":"Acta Tuberculosea et Pneumologica Belgica"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000239435","article-title":"Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong","volume":"42","author":"Chan","year":"1996","journal-title":"Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1183\/09031936.00104209","article-title":"Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?","volume":"35","author":"Chang","year":"2010","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1745-6215-13-156","article-title":"Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo controlled trial","volume":"13","author":"Chang","year":"2012","journal-title":"Trials"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archinte.1959.00270030001001","article-title":"Long-term treatment of bronchiectasis and chronic bronchitis","volume":"103","author":"Cherniack","year":"1959","journal-title":"AMA Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0002-9343(66)90218-X","article-title":"Factors associated with respiratory insufficiency in bronchiectasis","volume":"41","author":"Cherniack","year":"1966","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0067|cit67","first-page":"1385","article-title":"A study about IgG subclass concentration of chronic cough patient and changes of immunoglobulin levels after RU 41.740 administration","volume":"39","author":"Choi","year":"1996","journal-title":"Korean Journal of Pediatrics"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001392.pub3-BIB0068|cit68","first-page":"586","article-title":"Clinical study of TE-031 (A-56268) in the treatment of 17 patients with respiratory infections [Japanese]","volume":"36","author":"Chonabayashi","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl 9","key":"10.1002\/14651858.CD001392.pub3-BIB0069|cit69","first-page":"694","article-title":"Clinical studies of T-3262 in respiratory tract infection [Japanese]","volume":"36","author":"Chonabayashi","year":"1988","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0070|cit70","first-page":"34","article-title":"[Effectiveness of ciprofloxacin in the treatment of hospital infections of the lower respiratory tract]","volume":"42","author":"Chuchalin","year":"1997","journal-title":"Antibiotiki i Khimioterapiia [Antibiotics and Chemotherapy]"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jac\/7.3.311","article-title":"Co-trimoxazole-ascorbic acid in the treatment of chronic Pseudomonas aeruginosa infection of the lower respiratory tract","volume":"7","author":"Clarke","year":"1981","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD001392.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1164\/ajrccm.160.5.9810080","article-title":"Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study","volume":"160","author":"Crowther Labiris","year":"1999","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0073|cit73","first-page":"115","article-title":"Treatment with Sumetrolim in chronic non-specific respiratory tract infections","volume":"23","author":"Cseri","year":"1975","journal-title":"Therapia Hungarica"},{"issue":"6590","key":"10.1002\/14651858.CD001392.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/bmj.295.6590.119-a","article-title":"Penetration of antibiotics into the respiratory tract","volume":"295","author":"Currie","year":"1987","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0075|cit75","first-page":"153","article-title":"Surgical results in primary bronchiectasis","volume":"129","author":"Czako","year":"1968","journal-title":"Zeitschrift fur Tuberkulose und Erkrankungen der Thoraxorgane"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0076|cit76","first-page":"175","article-title":"Clinical study on the efficacy of clofoctol in the treatment of infectious respiratory diseases","volume":"5","author":"Danesi","year":"1985","journal-title":"International Journal of Clinical Pharmacology Research"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/12.suppl_A.1","article-title":"Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime","volume":"12(Suppl A)","author":"Davies","year":"1983","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0078|cit78","first-page":"27","article-title":"Giramid in lung diseases","volume":"27","author":"Dobrev","year":"1990","journal-title":"Pnevmologiya i Ftiziatriya"},{"issue":"6988","key":"10.1002\/14651858.CD001392.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(57)91597-0","article-title":"Effect of antibiotics on purulent sputum in chronic bronchitis and bronchiectasis","volume":"273","author":"Douglas","year":"1957","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0080|cit80","first-page":"II","article-title":"Laboratory and clinical studies on NY-198 [Japanese]","volume":"36","author":"Doutsu","year":"1988","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/clinids\/3.1.150","article-title":"Controlled comparative trial of bacampicillin and amoxicillin in therapy of bacterial infections of the lower respiratory tract","volume":"3","author":"Finegold","year":"1981","journal-title":"Reviews of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1128\/AAC.37.4.804","article-title":"Ecology of Haemophilus influenzae and Haemophilus parainfluenzae in sputum and saliva and effects of antibiotics on their distribution in patients with lower respiratory tract infections","volume":"37","author":"Foweraker","year":"1993","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/bmj.2.4845.1067","article-title":"Chloramphenicol treatment of bronchiectasis in children","volume":"2","author":"Franklin","year":"1953","journal-title":"British Medical Journal"},{"issue":"Suppl B","key":"10.1002\/14651858.CD001392.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jac\/14.suppl_B.301","article-title":"A comparison of cefotaxime and cefoperazone in respiratory tract infections","volume":"14","author":"Garcia Rodriquez","year":"1984","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0085|cit85","first-page":"337","article-title":"Substitution of cefamandol by cefonicid. A prospective study of use according to protocol","volume":"5","author":"Grau","year":"1992","journal-title":"Revista Espanola de Quimioterapia"},{"issue":"9","key":"10.1002\/14651858.CD001392.pub3-BIB0086|cit86","first-page":"514","article-title":"Effect of inhalation of tobramycin for 12 months on reduction of hospitalisation rate in severe COPD","volume":"67","author":"Haidl","year":"2013","journal-title":"Pneumologie"},{"issue":"11","key":"10.1002\/14651858.CD001392.pub3-BIB0087|cit87","first-page":"923","article-title":"Clinical investigation of ciprofloxacin IV in severe and\/or refractory infections in the internal medicine field","volume":"45","author":"Hara","year":"1997","journal-title":"Japanese Journal of Chemotherapy"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD001392.pub3-BIB0088|cit88","first-page":"237","article-title":"Ampicillin in lower respiratory tract infections [Japanese]","volume":"36","author":"Harada","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0089|cit89","first-page":"565","article-title":"Basic and clinical studies on cefdinir [Japanese]","volume":"37","author":"Hayashi","year":"1989","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0140-6736(56)91240-5","article-title":"Long-term oxytetracycline (terramycin) therapy in advanced chronic respiratory infections","volume":"1","author":"Helm","year":"1956","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0091|cit91","first-page":"130","article-title":"Pulmonary function and quality of life in relation to bronchial colonization in adults with bronchiectasis not caused by cystic fibrosis","volume":"118","author":"Hernandez","year":"2002","journal-title":"Medicina Clinica"},{"issue":"7","key":"10.1002\/14651858.CD001392.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/thx.41.7.559","article-title":"Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation","volume":"41","author":"Hill","year":"1986","journal-title":"Thorax"},{"issue":"250","key":"10.1002\/14651858.CD001392.pub3-BIB0093|cit93","first-page":"163","article-title":"The response of patients with purulent bronchiectasis to antibiotics for four months","volume":"66","author":"Hill","year":"1988","journal-title":"Quarterly Journal of Medicine"},{"issue":"Suppl 15","key":"10.1002\/14651858.CD001392.pub3-BIB0094|cit94","first-page":"142s","article-title":"Sputum and serum pharmacokinetics of loracarbef (a new carbacephem antibiotic) in patients with bronchiectasis [Abstract]","volume":"5","author":"Hill","year":"1992","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/33.1.129","article-title":"Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis","volume":"33","author":"Hill","year":"1994","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0096|cit96","unstructured":"Hossain A Ahamed M Sharkar ZH Change in clinical outcome of exacerbation of bronchiectasis on addition of nebulised gentamicin to systemic antibiotics Congress of the Asian Pacific Society of Respirology; 2010; 22-25 Nov; Manila 2010"},{"issue":"6040","key":"10.1002\/14651858.CD001392.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/bmj.2.6040.882-c","article-title":"Antibiotics and purulent sputum","volume":"2","author":"Howie","year":"1976","journal-title":"British Medical Journal"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD001392.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5694\/j.1326-5377.1973.tb111191.x","article-title":"Use of combinations of trimethoprim and sulphamethoxazole in the treatment of chest infections","volume":"1","author":"Hughes","year":"1973","journal-title":"Medical Journal of Australia"},{"issue":"Nov Suppl","key":"10.1002\/14651858.CD001392.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/infdis\/128.Supplement_3.S701","article-title":"Use of combinations of trimethoprim and sulfamethoxazole in the treatment of chest infections","volume":"128","author":"Hughes","year":"1973","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0100|cit100","first-page":"II","article-title":"Antimicrobial activity and clinical evaluation of NY-198. [Japanese]","volume":"36","author":"Ida","year":"1988","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/archotol.1993.01880180064012","article-title":"Erythromycin therapy for otitis media with effusion in sinobronchial syndrome","volume":"119","author":"Iino","year":"1993","journal-title":"Archives of Otolaryngology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001392.pub3-BIB0102|cit102","first-page":"285","article-title":"Basic and clinical studies on 7432-S. [Japanese]","volume":"37","author":"Inoue","year":"1989","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0954-6111(93)90072-8","article-title":"Effect of antibiotics on sputum inflammatory contents in acute exacerbations of bronchiectasis","volume":"87","author":"Ip","year":"1993","journal-title":"Respiratory Medicine"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD001392.pub3-BIB0104|cit104","first-page":"A173","article-title":"Randomised controlled study of levofloxacin versus ceftazidime in acute exacerbations of bronchiectasis","volume":"157","author":"Ip","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0105|cit105","first-page":"603","article-title":"Laboratory and clinical studies on cefdinir. [Japanese]","volume":"37","author":"Irabu","year":"1989","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0106|cit106","first-page":"452","article-title":"Laboratory and clinical studies of ME1207. [Japanese]","volume":"40","author":"Irabu","year":"1992","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0107|cit107","first-page":"716","article-title":"Clinical studies of tazobactam\/piperacillin in respiratory tract infection","volume":"42","author":"Izumi","year":"1994","journal-title":"Chemotherapy"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001392.pub3-BIB0108|cit108","first-page":"729","article-title":"Basic and clinical studies on TE-031 (A-56268) in treatment of respiratory tract infections [Japanese]","volume":"36","author":"Izumikawa","year":"1988","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000319952","article-title":"A multicenter, randomized controlled clinical study on biapenem and imipenem\/cilastatin injection in the treatment of respiratory and urinary tract infections","volume":"56","author":"Jia","year":"2010","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0110|cit110","first-page":"II","article-title":"Clinical studies on NY-198. [Japanese]","volume":"36","author":"Kaji","year":"1988","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0111|cit111","first-page":"25","article-title":"Clinical trial use of phenoxypropyl penicillin","volume":"16","author":"Kanai","year":"1963","journal-title":"Journal of Antibiotics"},{"issue":"12","key":"10.1002\/14651858.CD001392.pub3-BIB0112|cit112","first-page":"647","article-title":"Treatment of respiratory tract infections with a combination of amoxycillin and clavulanic acid","volume":"23","author":"Karachalios","year":"1985","journal-title":"International Journal of Clinical Pharmacology, Therapy, and Toxicology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0113|cit113","first-page":"II","article-title":"NY-198 in the treatment of respiratory infections. [Japanese]","volume":"36","author":"Kawai","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0114|cit114","first-page":"II","article-title":"Clinical trial with NY-198 against respiratory tract infections. [Japanese]","volume":"36","author":"Nakatani","year":"1988","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0115|cit115","first-page":"594","article-title":"Clincial study on NM441 in respiratory tract infections. [Japanese]","volume":"44","author":"Kawai","year":"1996","journal-title":"Japanese Journal of Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0116|cit116","first-page":"446","article-title":"Studies on amikacin (BB-K8), a new aminoglycoside antibiotic (author's transl)","volume":"27","author":"Kawano","year":"1974","journal-title":"Japanese Journal of Antibiotics"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0117|cit117","first-page":"1268","article-title":"Clinical role of Branhamella catarrhalis infection in pulmonary disorders. [Japanese]","volume":"44","author":"Kawashima","year":"1989","journal-title":"Saishin Igaku [Modern Medicine]"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"Kellett","year":"2011","journal-title":"Respiratory Medicine"},{"issue":"8","key":"10.1002\/14651858.CD001392.pub3-BIB0119|cit119","first-page":"839","article-title":"Clinical evaluation of ciprofloxacin in pulmonary infections in the patients with chronic respiratory diseases","volume":"44","author":"Kikuchi","year":"1991","journal-title":"Japanese Journal of Antibiotics"},{"issue":"6855","key":"10.1002\/14651858.CD001392.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0140-6736(55)91698-6","article-title":"Chronic bronchitis: an attempt to control chronic infection by Haemophilus Influenzae by aerosol therapy","volume":"268","author":"Knox","year":"1955","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0121|cit121","first-page":"525","article-title":"Comparison of DL-8280 and amoxicillin in the treatment of respiratory tract infections","volume":"58","author":"Kobayashi","year":"1984","journal-title":"Journal of the Japanese Association for Infectious Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001392.pub3-BIB0122|cit122","first-page":"333","article-title":"Clinical evaluation of grepafloxacin in the treatment of various infectious diseases in the field of internal medicine","volume":"43","author":"Kobayashi","year":"1995","journal-title":"Japanese Journal of Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1378\/chest.117.2.427","article-title":"The effect of regular salbutamol on lung function and bronchial responsiveness in patients with primary ciliary dyskinesia","volume":"117","author":"Koh","year":"2000","journal-title":"Chest"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0124|cit124","first-page":"692","article-title":"ME1207: a clinical study. [Japanese]","volume":"40","author":"Koyama","year":"1992","journal-title":"Chemotherapy"},{"issue":"25","key":"10.1002\/14651858.CD001392.pub3-BIB0125|cit125","first-page":"927","article-title":"Comparative evaluation of certain antibiotics and Biceptol preparation in the treatment of chronic bronchial disease exacerbations. [Polish]","volume":"36","author":"Krawczyk","year":"1981","journal-title":"Polski Tygodnik Lekarski"},{"issue":"8","key":"10.1002\/14651858.CD001392.pub3-BIB0126|cit126","first-page":"743","article-title":"[Chemotherapy of respiratory diseases]. [Russian]","volume":"16","author":"Krofton","year":"1971","journal-title":"Antibiotiki"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001392.pub3-BIB0127|cit127","first-page":"617","article-title":"Preclinical and clinical studies on TE-031 (A-56268) in treatment of bacterial respiratory tract infections. [Japanese]","volume":"36","author":"Kudo","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0128|cit128","first-page":"696","article-title":"ME1207 in respiratory infections. [Japanese]","volume":"40","author":"Kudo","year":"1992","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0129|cit129","first-page":"13","article-title":"Anaerobes in pleuropulmonary infections","volume":"3","author":"Kulpati","year":"1990","journal-title":"Journal International Medical Sciences Academy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0130|cit130","first-page":"II","article-title":"NY-198 in the treatment of respiratory infections. [Japanese]","volume":"36","author":"Kurasawa","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001392.pub3-BIB0131|cit131","first-page":"273","article-title":"Basic and clinical studies on cefclidin. [Japanese]","volume":"40","author":"Kurishima","year":"1992","journal-title":"Chemotherapy"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD001392.pub3-BIB0132|cit132","first-page":"467","article-title":"Cefodizime (THR-221) in respiratory tract infections. [Japanese]","volume":"36","author":"Kuze","year":"1988","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1007\/BF01661296","article-title":"A double-blind randomized study comparing ofloxacin and amoxicillin in treating infective episodes in bronchiectasis","volume":"14(Suppl 4)","author":"Lam","year":"1986","journal-title":"Infection"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0954-6111(89)80200-8","article-title":"Ofloxacin compared with amoxycillin in treating infective exacerbations in bronchiectasis","volume":"83","author":"Lam","year":"1989","journal-title":"Respiratory Medicine"},{"issue":"11","key":"10.1002\/14651858.CD001392.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1164\/rccm.200509-1531OC","article-title":"Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease","volume":"173","author":"Lam","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"14","key":"10.1002\/14651858.CD001392.pub3-BIB0136|cit136","first-page":"969","article-title":"Bronchiectasis. [French]","volume":"34","author":"Lamotte","year":"1981","journal-title":"Ouest-Medical"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/thorax.55.1.91a","article-title":"Nebulised taurolidine and B cepacia bronchiectasis","volume":"55","author":"Ledson","year":"2000","journal-title":"Thorax"},{"issue":"23","key":"10.1002\/14651858.CD001392.pub3-BIB0138|cit138","first-page":"400s","article-title":"Amoxicillin down-regulates the release of neutrophil derived pro-inflammatory cytokines and C5a in patients with bronchiectasis","volume":"9","author":"Lin","year":"1996","journal-title":"European Respiratory Journal"},{"issue":"Suppl 9","key":"10.1002\/14651858.CD001392.pub3-BIB0139|cit139","first-page":"400s","article-title":"Erithromycin upregulates \u03b22-Integrins (CD11B\/CD118) expression and intracellular oxidant capacity in airway neurophils of patients with bronchiectasis","volume":"23","author":"Lin","year":"1996","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1164\/ajrccm.155.6.9196111","article-title":"Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis","volume":"155","author":"Lin","year":"1997","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD001392.pub3-BIB0141|cit141","first-page":"455","article-title":"A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population. [Chinese].","volume":"27","author":"Lin","year":"2004","journal-title":"Chinese Journal of Tuberculosis and Respiratory Diseases"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1185\/030079906X80297","article-title":"A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population","volume":"22","author":"Lin","year":"2006","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0143|cit143","first-page":"88S","article-title":"Intermittent antibiotic treatment in patients with stable bronchiectasis: a comparative study between amoxycillin and cefonicid [abstract]","volume":"3(Suppl 10)","author":"Lioberes","year":"1990","journal-title":"European Respiratory Journal Supplement"},{"issue":"12","key":"10.1002\/14651858.CD001392.pub3-BIB0144|cit144","first-page":"1123","article-title":"Intratracheal use of morphocycline. [Russian]","volume":"13","author":"Lunacharskaia","year":"1968","journal-title":"Antibiotiki"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0145|cit145","first-page":"140","article-title":"Clinical results of the use of cephaloridine in lung diseases, especially pulmonary tuberculosis. [Japanese]","volume":"20","author":"Maekawa","year":"1967","journal-title":"Journal of Antibiotics [B]"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0011-393X(05)80649-6","article-title":"Pefloxacin in the treatment of nosocomial respiratory tract infections","volume":"54","author":"Mahashur","year":"1993","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0147|cit147","first-page":"393","article-title":"Study of the efficacy of immunomodulator imunocin, as an add-on therapy in the management of patients with chronic obstructive pulmonary disorder and bronchiectasis","volume":"55","author":"Mahashur","year":"2002","journal-title":"Indian Practitioner"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0148|cit148","first-page":"044","article-title":"Lack of efficacy of an immunomodulatory macrolide in childhood","volume":"5","author":"Masekela","year":"2013","journal-title":"Journal of Antivirals & Antiretrovirals"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001392.pub3-BIB0149|cit149","first-page":"331","article-title":"A clinical study of cefclidin [Japanese]","volume":"40","author":"Masuno","year":"1992","journal-title":"Chemotherapy"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001392.pub3-BIB0150|cit150","first-page":"434","article-title":"Laboratory and clinical evaluation on ceftazidime with the special reference to respiratory infections caused by Pseudomonas aeruginosa","volume":"31","author":"Matsumoto","year":"1983","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0151|cit151","first-page":"824","article-title":"Asian multicenter trial of cefoperazone in respiratory tract infection","volume":"6","author":"Matsumoto","year":"1984","journal-title":"Clinical Therapeutics"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD001392.pub3-BIB0152|cit152","first-page":"397","article-title":"Laboratory and clinical evaluation of lenampicillin (KBT-1585) in respiratory infection. [Japanese]","volume":"32","author":"Matsumoto","year":"1984","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0153|cit153","first-page":"316","article-title":"A study on the evaluation of the efficacy of chemotherapy for chronic respiratory tract infections. [Japanese]","volume":"34","author":"Matsumoto","year":"1986","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0154|cit154","first-page":"740","article-title":"Clinical studies on ME1207 in the treatment of respiratory tract infections. [Japanese]","volume":"40","author":"Matsumoto","year":"1992","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0155|cit155","first-page":"II","article-title":"Clinical study of NY-198 in pulmonary infections. [Japanese]","volume":"36","author":"Matsushima","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001392.pub3-BIB0156|cit156","first-page":"795","article-title":"Clinical studies of S-1108 in elderly patients","volume":"41","author":"Matsuura","year":"1993","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0157|cit157","first-page":"503","article-title":"The use of sisomicin in chronic bronchopulmonary disorders","volume":"7","author":"Matzeu","year":"1981","journal-title":"Drugs Under Experimental and Clinical Research"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0007-0971(72)90029-0","article-title":"Amoxycillin in the treatment of chronic non-tuberculous bronchial infections","volume":"66","author":"May","year":"1972","journal-title":"British Journal of Diseases of the Chest"},{"issue":"Suppl","key":"10.1002\/14651858.CD001392.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1093\/infdis\/129.Supplement_2.S189","article-title":"Amoxicillin in the treatment of infections of the lower respiratory tract","volume":"129","author":"May","year":"1974","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0160|cit160","first-page":"85","article-title":"Amoxicillin in the treatment of lower respiratory infections","volume":"7","author":"May","year":"1974","journal-title":"Advances in Clinical Pharmacology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001392.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2165\/00003495-199300453-00176","article-title":"Ciprofloxacin in the treatment of lower respiratory tract infections","volume":"46","author":"Mazzei","year":"1993","journal-title":"Drugs"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/archinte.1953.00240240069005","article-title":"Antibiotic prophylaxis in chronic respiratory diseases","volume":"92","author":"McVay","year":"1953","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0163|cit163","first-page":"251","article-title":"Comparative study of amoxycillin and amoxycillin\/clavulanic acid in lower respiratory infections","volume":"39","author":"Mehta","year":"1991","journal-title":"Journal of the Association of Physicians of India"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/17843286.1973.11716858","article-title":"[Double-blind study of the sulfamethoxazole-trimethoprim association in the treatment of pulmonary infections]","volume":"28","author":"Messens","year":"1973","journal-title":"Acta Clinica Belgica"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0165|cit165","first-page":"229","article-title":"Bisolvomycin and Bisolvon in the treatment of chronic bronchitis, bronchial asthma and bronchiectasis","volume":"24","author":"Mijuskovic","year":"1972","journal-title":"Plucne Bolesti i Tuberkuloza"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0166|cit166","first-page":"20","article-title":"Antibacterial treatment of anaerobic lung infections. [Bulgarian]","volume":"22","author":"Milcev","year":"1985","journal-title":"Pnevmologiya i Ftiziatriya"},{"issue":"7","key":"10.1002\/14651858.CD001392.pub3-BIB0167|cit167","first-page":"335","article-title":"Clinical evaluation of TE-031 in the chronic respiratory infections. [Japanese]","volume":"16","author":"Min","year":"1988","journal-title":"Japanese Pharmacology and Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD001392.pub3-BIB0168|cit168","first-page":"845","article-title":"Combination regimen of low dose erythromycin and ofloxacin against chronic airway infections","volume":"55","author":"Minami","year":"1996","journal-title":"Japanese Journal of Chest Diseases"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001392.pub3-BIB0169|cit169","first-page":"A168","article-title":"Efficacy of macrolide and theophylline in the management of bronchiectasis [Abstract]","volume":"10","author":"Ming","year":"2005","journal-title":"Respirology (Carlton, Vic)"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001392.pub3-BIB0170|cit170","first-page":"441","article-title":"Experience with AT-2266. [Japanese]","volume":"32","author":"Miyamoto","year":"1984","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0171|cit171","first-page":"90","article-title":"[Cleansing of the bronchial tree in treating chronic inflammatory lung disease]. [Russian]","volume":"11","author":"Molodtsova","year":"1980","journal-title":"Sovetskaia Meditsina"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0172|cit172","first-page":"253","article-title":"Pulmonary infections in adults: two therapeutics regimens of ofloxacin","volume":"98","author":"Morrone","year":"1989","journal-title":"A Folha M\u00c3\u00a9dica"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0173|cit173","first-page":"724","article-title":"A clinical study of the effects of ME1207 on respiratory infections. [Japanese]","volume":"40","author":"Murayama","year":"1992","journal-title":"Chemotherapy"},{"issue":"3-4","key":"10.1002\/14651858.CD001392.pub3-BIB0174|cit174","first-page":"187","article-title":"Comparison of amoxicillin and amoxiclav in the therapy of respiratory infections","volume":"41","author":"Music","year":"1989","journal-title":"Plucne Bolesti: Casopis Udruzenja Pneumoftiziologa Jugoslavije [Journal of Yugoslav Association of Physiology and Pneumology]"},{"issue":"5","key":"10.1002\/14651858.CD001392.pub3-BIB0175|cit175","first-page":"283","article-title":"[Late results of the conservative treatment of bronchiectasis in adults]. [German]","volume":"127","author":"Nagy","year":"1968","journal-title":"Zeitschrift fur Tuberkulose und Erkrankungen der Thoraxorgane"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001392.pub3-BIB0176|cit176","first-page":"803","article-title":"Clinical study of S-1108 in respiratory infections","volume":"41","author":"Nakagawa","year":"1993","journal-title":"Chemotherapy"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD001392.pub3-BIB0177|cit177","first-page":"547","article-title":"Clinical effect of balofloxacin in respiratory tract infections. [Japanese]","volume":"43","author":"Nakagawa","year":"1995","journal-title":"Japanese Journal of Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD001392.pub3-BIB0178|cit178","first-page":"539","article-title":"Sputum penetration of levofloxacin and its clinical efficacy in patients with chronic lower respiratory tract infections. [Japanese]","volume":"45","author":"Nakamori","year":"1992","journal-title":"Japanese Journal of Antibiotics"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0179|cit179","first-page":"451","article-title":"[Comparison of 5 day short-course therapies for secondary infection in patients with chronic respiratory disease using gatifloxacin and levofloxacin]","volume":"55","author":"Nakamura","year":"2007","journal-title":"Japanese Journal of Chemotherapy"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD001392.pub3-BIB0180|cit180","first-page":"361","article-title":"Clinical efficacy of temafloxacin in respiratory infections and its pharmacokinetics in sputum","volume":"41","author":"Nakatani","year":"1993","journal-title":"Chemotherapy"},{"issue":"Suppl 9","key":"10.1002\/14651858.CD001392.pub3-BIB0181|cit181","first-page":"699","article-title":"T-3262 in respiratory tract infections. [Japanese]","volume":"36","author":"Nasu","year":"1988","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1159\/000220158","article-title":"Clinical trials of the new antibiotic, rifamycin sv: preliminary report","volume":"12","author":"Neumayr","year":"1963","journal-title":"Chemotherapy"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD001392.pub3-BIB0183|cit183","first-page":"373","article-title":"Clinical study on BAY o 9867 in the field of internal medicine. [Japanese]","volume":"33","author":"Nobuoka","year":"1985","journal-title":"Chemotherapy"},{"issue":"12","key":"10.1002\/14651858.CD001392.pub3-BIB0184|cit184","first-page":"1044","article-title":"Augmentin (intravenous then oral) compared with cefuroxime followed by cephalexin for chest infections in hospitalised patients","volume":"41","author":"O'Donovan","year":"1987","journal-title":"British Journal of Clinical Practice"},{"issue":"10","key":"10.1002\/14651858.CD001392.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1128\/iai.62.10.4145-4152.1994","article-title":"Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases","volume":"62","author":"Oishi","year":"1994","journal-title":"Infection and Immunity"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0186|cit186","first-page":"15","article-title":"[Therapeutic effect of amikacin for infections with gram-negative bacilli, especially for stubborn respiratory infections (author's transl)]. [Japanese]","volume":"31","author":"Oizumi","year":"1978","journal-title":"Japanese Journal of Antibiotics"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0187|cit187","first-page":"54","article-title":"An evaluation of low dose long term erythromycin chemotherapy in bronchiectasis","volume":"52","author":"Oki","year":"1993","journal-title":"Japanese Journal of Chest Diseases"},{"issue":"9","key":"10.1002\/14651858.CD001392.pub3-BIB0188|cit188","first-page":"29","article-title":"Antibiotic therapy of bronchial pyoinflammation using endobronchial low-frequency ultrasound. [Russian]","volume":"69","author":"Ovcharenko","year":"1991","journal-title":"Klinicheskaia Meditsina"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0189|cit189","unstructured":"Patterson JE Bradley JM Hewit O Bradbury I Elborn JS Airway clearance during oral antibiotic therapy in bronchiectasis, a randomized trial of acapella versus usual airway clearance [Abstract] American Thoracic Society 2005 International Conference; May 20-25; San Diego, California 2005 B25; Poster: 917"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1479972306075483","article-title":"Acapella versus 'usual airway clearance' during acute exacerbation in bronchiectasis: a randomized crossover trial","volume":"4","author":"Patterson","year":"2007","journal-title":"Chronic Respiratory Disease"},{"issue":"1-2","key":"10.1002\/14651858.CD001392.pub3-BIB0191|cit191","first-page":"17","article-title":"[Clinical study of a new cephalosporin: ceftriaxone (RO 13-9904) in resurgent acute and chronic bronchopneumopathies]. [Italian]","volume":"38","author":"Pezza","year":"1983","journal-title":"Archivio Monaldi per la Tisiologia e le Malattie dell'Apparato Respiratorio"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0007-0971(67)80033-0","article-title":"Cephaloridine compared with penicillin and streptomycin in chronic purulent bronchitis. Controlled trials of increasing dosage of cephaloridine","volume":"61","author":"Pines","year":"1967","journal-title":"British Journal of Diseases of the Chest"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0007-0971(79)90079-2","article-title":"Cefuroxime in severe respiratory infections: a double-blind comparison of two doses","volume":"73","author":"Pines","year":"1979","journal-title":"British Journal of Diseases of the Chest"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000238016","article-title":"Cefuroxime and ampicillin compared in a double-blind study in the treatment of lower respiratory tract infections","volume":"27","author":"Pines","year":"1981","journal-title":"Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD001392.pub3-BIB0195|cit195","first-page":"674","article-title":"Cefodizime once daily in the treatment of lower respiratory tract infections","volume":"47","author":"Piovano","year":"1997","journal-title":"Arzneimittel-Forschung"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0196|cit196","first-page":"30","article-title":"Peflacin - clinical study in patients with pulmonary diseases. [Bulgarian]","volume":"25","author":"Popov","year":"1988","journal-title":"Pnevmologiya i Ftiziatriya"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/jac\/21.suppl_B.131","article-title":"Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin","volume":"21(Suppl B)","author":"Prigogine","year":"1988","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"48","key":"10.1002\/14651858.CD001392.pub3-BIB0198|cit198","first-page":"1823","article-title":"[Trimethoprim-sulfamethoxazole versus amoxycillin in the therapy of acute bacterial exacerbations in chronic non-specific respiratory tract diseases: a controlled study]","volume":"111","author":"Ramer","year":"1981","journal-title":"Schweizerische Medizinische Wochenschrift"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/34.1.149","article-title":"Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis","volume":"34","author":"Rayner","year":"1994","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0200|cit200","first-page":"891","article-title":"Use of miocamycin in respiratory infection","volume":"23","author":"Rimoldi","year":"1987","journal-title":"Annali dell'Istituto Superiore di Sanita"},{"issue":"11","key":"10.1002\/14651858.CD001392.pub3-BIB0201|cit201","first-page":"1232","article-title":"A study of the clinical effects of clindamycin on respiratory infections - Focusing on inhibition of beta-lactamase production. [Japanese]","volume":"41","author":"Saito","year":"1993","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0202|cit202","first-page":"419","article-title":"Dose-finding study of gatifloxacin, a new oral, quinolone, in chronic respiratory tract infection. [Japanese]","volume":"47","author":"Saito","year":"1999","journal-title":"Japanese Journal of Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD001392.pub3-BIB0203|cit203","first-page":"646","article-title":"Clinical studies of gatifloxacin for infections in internal medicine","volume":"50","author":"Saito","year":"2002","journal-title":"Japanese Journal of Chemotherapy"},{"issue":"Suppl","key":"10.1002\/14651858.CD001392.pub3-BIB0204|cit204","first-page":"42","article-title":"Effectiveness of inhaled antibiotic treatment for Pseudomonas aeruginosa in outpatients with colonized bronchiectasis without mucoviscidosis [Abstract]","volume":"31","author":"Santiveri","year":"1995","journal-title":"Archivos de Bronconeumologia"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0205|cit205","first-page":"48","article-title":"Clinical studies on the utility of ofloxacin for lower respiratory infections","volume":"44","author":"Sawae","year":"1991","journal-title":"Japanese Journal of Antibiotics"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2165\/00003495-199500492-00125","article-title":"A comparative study of ofloxacin twice and three times daily in the treatment of respiratory tract infections","volume":"49","author":"Sawae","year":"1995","journal-title":"Drugs"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0207|cit207","first-page":"37","article-title":"The long term chemotherapy with erythromycin in chronic lower respiratory tract infections: first report - comparing with amoxicillin","volume":"60","author":"Sawaki","year":"1986","journal-title":"Japanese Association of Infectious Disease"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0208|cit208","first-page":"185","article-title":"[Comparative studies on the toxicity of tetracyclines and chloramphenicol in the treatment of nonspecific bronchopulmonary infections]. [German]","volume":"136","author":"Schulz","year":"1972","journal-title":"Zeitschrift fur Erkrankungen der Atmungsorgane mit Folia Bronchologica"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.rmed.2011.01.009","article-title":"Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations","volume":"105","author":"Serisier","year":"2011","journal-title":"Respiratory Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD001392.pub3-BIB0210|cit210","first-page":"62 [TP-100]","article-title":"Research bronchoscopic biopsy in adult bronchiectasis subjects is associated with significant bleeding risk","volume":"16","author":"Serisier","year":"2011","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0211|cit211","unstructured":"Shrewsbury SB Bilton D Gotfried M Jones SA American Thoracic Society 100th International conference; 2004 May 21-26; Orlando Orlando 2004 A42 Poster A53"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD001392.pub3-BIB0212|cit212","first-page":"382","article-title":"Laboratory and clinical studies on lenampicillin (KBT-1585) a new penicillin antibiotic. [Japanese]","volume":"32","author":"Shigeno","year":"1984","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0213|cit213","first-page":"231","article-title":"A dose-finding study on pazufloxacin in chronic respiratory tract infections","volume":"44","author":"Shimada","year":"1996","journal-title":"Japanese Journal of Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0214|cit214","first-page":"701","article-title":"Antimicrobial activity and clinial evaluation of NY-198","volume":"36","author":"Shimada","year":"1988","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0215|cit215","first-page":"14","article-title":"Evaluation of imipenem\/cilastatin sodium in the treatment of respiratory tract infections","volume":"43","author":"Shimokata","year":"1990","journal-title":"Japanese Journal of Antibiotics"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001392.pub3-BIB0216|cit216","first-page":"748","article-title":"Evaluation of cefclidin on respiratory tract infections","volume":"40","author":"Shimokata","year":"1992","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2169\/internalmedicine.34.469","article-title":"Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity","volume":"34","author":"Shirai","year":"1995","journal-title":"Internal Medicine"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD001392.pub3-BIB0218|cit218","first-page":"257","article-title":"Sultbactam.ampicillin (1:2) in respiratory tract infections with special reference to beta-lactamase-producing organisms","volume":"36","author":"Shishido","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2165\/00003495-199500492-00126","article-title":"Oral levofloxacin 600mg and 300mg daily doses in difficult-to-treat respiratory infections","volume":"49","author":"Shishido","year":"1995","journal-title":"Drugs"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001392.pub3-BIB0220|cit220","first-page":"A192","article-title":"Multicentre bronchiectasis study; a collaboration and international study of bronchiectasis in indigenous children [Abstract]","volume":"12","author":"Singleton","year":"2007","journal-title":"Respirology (Carlton, Vic)"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0221|cit221","first-page":"A19","article-title":"Multicentre bronchiectasis study: an international observational and interventional study of bronchiectasis in indigenous children [Abstract]","volume":"13","author":"Singleton","year":"2008","journal-title":"Respirology (Carlton, Vic)"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001392.pub3-BIB0222|cit222","first-page":"673","article-title":"Clinical studies on TE-031 (A-56268)","volume":"36","author":"Soejima","year":"1988","journal-title":"Chemotherapy"},{"issue":"Meeting Abstrac","key":"10.1002\/14651858.CD001392.pub3-BIB0223|cit223","first-page":"A1507","article-title":"Lung deposition of ciprofloxacin dry powder for inhalation in healthy subjects and patients suffering from chronic obstructive pulmonary disease or non-cystic fibrosis bronchiectasis","volume":"187","author":"Stass","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/thx.39.6.414","article-title":"Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state","volume":"39","author":"Stockley","year":"1984","journal-title":"Thorax"},{"issue":"5","key":"10.1002\/14651858.CD001392.pub3-BIB0225|cit225","first-page":"593","article-title":"Nebulized amoxicillin in chronic purulent bronchiectasis","volume":"7","author":"Stockley","year":"1985","journal-title":"Clinical Therapeutics"},{"issue":"Suppl 9","key":"10.1002\/14651858.CD001392.pub3-BIB0226|cit226","first-page":"694","article-title":"Clinical studies of T-3262 in respiratory tract infection. [Japanese]","volume":"36","author":"Suga","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD001392.pub3-BIB0227|cit227","first-page":"529","article-title":"Laboratory and clinical studies on cefodizime (THR-221)","volume":"36","author":"Suyama","year":"1988","journal-title":"Chemotherapy"},{"issue":"Suppl A","key":"10.1002\/14651858.CD001392.pub3-BIB0228|cit228","first-page":"33","article-title":"[Effect and action mechanism of short-term administration of calrithromycin for airway hypersecretion]. [Japanese]","volume":"54","author":"Tagaya","year":"2001","journal-title":"Japanese Journal of Antibiotics"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1378\/chest.122.1.213","article-title":"Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion","volume":"122","author":"Tagaya","year":"2002","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/jam.1994.7.345","article-title":"Nebulizer therapy with antibiotics in chronic suppurative lung disease","volume":"7","author":"El-Din","year":"1994","journal-title":"Journal of Aerosol Medicine"},{"issue":"9","key":"10.1002\/14651858.CD001392.pub3-BIB0231|cit231","first-page":"1131","article-title":"Imipenem\/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections","volume":"47","author":"Takamoto","year":"1994","journal-title":"Japanese Journal of Antibiotics"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001392.pub3-BIB0232|cit232","first-page":"737","article-title":"Clinical studies on cefclidin [Japanese]","volume":"40","author":"Tamura","year":"1992","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001392.pub3-BIB0233|cit233","first-page":"683","article-title":"A clinical study on ME1207 in respiratory infections","volume":"40","author":"Tanimoto","year":"1992","journal-title":"Chemotherapy"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001392.pub3-BIB0234|cit234","first-page":"751","article-title":"Clinical studies on S-1108 in respiratory infections","volume":"41","author":"Tanimoto","year":"1993","journal-title":"Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0954-6111(06)80233-7","article-title":"Effect of bromhexeine on sputum amoxycillin levels in lower respiratory infections","volume":"86","author":"Taskar","year":"1992","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0236|cit236","first-page":"84P","article-title":"The concentration of clarithromycin and its active 14-hydroxy metabolite in sputum of patients with bronchiectasis following single dose oral administration","volume":"35","author":"Tsang","year":"1993","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jac\/33.2.289","article-title":"The concentrations of clarithromycin and its 14-hydroxy metabolite in sputum of patients with bronchiectasis following single dose oral administration","volume":"33","author":"Tsang","year":"1994","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD001392.pub3-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1183\/09031936.99.14512069","article-title":"A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis","volume":"14","author":"Tsang","year":"1999","journal-title":"European Respiratory Journal"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001392.pub3-BIB0239|cit239","first-page":"544","article-title":"Clinical study on TE-031 (A56268) against respiratory infections","volume":"36","author":"Unoura","year":"1988","journal-title":"Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0240|cit240","first-page":"205","article-title":"Comparative clinical trial of cefoperazone vs ampicillin + tobramycin in severe bronchopulmonary and pleural infectious pathology","volume":"41","author":"Vergnon","year":"1985","journal-title":"Revue di Pneumologie Clinique"},{"issue":"8","key":"10.1002\/14651858.CD001392.pub3-BIB0241|cit241","first-page":"1907","article-title":"Clinical trials of netilmicin against respiratory tract infection","volume":"35","author":"Watanabe","year":"1982","journal-title":"Japanese Journal of Antibiotics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001392.pub3-BIB0242|cit242","first-page":"148","article-title":"In vitro antimicrobial activity of 7432-S and its therapeutic efficacy in chronic respiratory tract infections","volume":"37","author":"Watanabe","year":"1989","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"S384","DOI":"10.1007\/BF01715833","article-title":"Once daily versus every two week multidose ofloxacin in patients with acute exacerbations of chronic respiratory disease","volume":"19(Suppl 7)","author":"Watanabe","year":"1991","journal-title":"Infection"},{"issue":"10","key":"10.1002\/14651858.CD001392.pub3-BIB0244|cit244","first-page":"1194","article-title":"A well-controlled comparative clinical study of the combination regimen of ciprofloxacin plus erythromycin for the treatment of repeated acute exacerbations of chronic respiratory tract infections. [Japanese]","volume":"42","author":"Watanabe","year":"1994","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1620\/tjem.176.25","article-title":"Daily single-dose regimen and alternate-two-week triple-dose\/day regimen of oral ofloxacin for the prophylaxis and control of exacerbations of chronic respiratory tract infections","volume":"176","author":"Watanabe","year":"1995","journal-title":"Tohoku Journal of Experimental Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s101560170032","article-title":"Comparison of chest X-ray findings and other parameters in acute exacerbation of chronic bronchitis in Japan and the West","volume":"7","author":"Watanabe","year":"2001","journal-title":"Journal of Infection and Chemotherapy"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001392.pub3-BIB0247|cit247","first-page":"816","article-title":"Clinical study on S-1108 in respiratory tract infections","volume":"41","author":"Yamada","year":"1993","journal-title":"Chemotherapy"},{"issue":"Suppl 9","key":"10.1002\/14651858.CD001392.pub3-BIB0248|cit248","first-page":"567","article-title":"T-3262 in respiratory tract infection and effect on blood theophylline concentration","volume":"36","author":"Yamaki","year":"1988","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0249|cit249","first-page":"390","article-title":"The effect of low-dose longterm erythromycin on bronchiectasis","volume":"40","author":"Young","year":"1993","journal-title":"Tuberculosis and Respiratory Diseases"},{"issue":"6","key":"10.1002\/14651858.CD001392.pub3-BIB0250|cit250","first-page":"361","article-title":"Observations on the effect of sodium fosfomycin on the lower respiratory tract infection","volume":"28","author":"Zhang","year":"2003","journal-title":"Chinese Journal of Antibiotics"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0251|cit251","doi-asserted-by":"crossref","unstructured":"Aksamit T Bandel TJ Criollo M De Soyza A Elborn JS Operschall E The RESPIRE trials: two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis Contemporary clinical trials 2017 78 85","DOI":"10.1016\/j.cct.2017.05.007"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0252|cit252","doi-asserted-by":"crossref","unstructured":"Alder J Hampel B Reimnitz P Wilson R Correlation of bacterial species and density at baseline to exacerbations requiring antibiotic treatment in a phase 2 trial of ciprofloxacin dry powder for inhalation (ciprofloxacin DPI) compared with placebo in patients with non-cystic fibrosis bronchiectasis American journal of respiratory and critical care medicine 2012","DOI":"10.1164\/ajrccm-conference.2012.185.1_MeetingAbstracts.A6099"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0253|cit253","doi-asserted-by":"crossref","unstructured":"Altenburg J Wilms E Boersma W The relationship between serum-and sputum levels of azithromycin and clinical endpoints in bronchiectasis patients in bronchiectasis patients using maintenance treatment Pneumologie (stuttgart, germany) 2016","DOI":"10.1055\/s-0036-1592227"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0254|cit254","doi-asserted-by":"crossref","unstructured":"Altenburg J Wolf R Go S van Rijn P Boersma W van der Werf T Changes of computed tomography features of bronchiectasis during one year of azithromycin treatment European respiratory journal 2016 OA278","DOI":"10.1183\/13993003.congress-2016.OA278"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0255|cit255","doi-asserted-by":"crossref","unstructured":"Altenburg J Wolf R Go S Van Rijn P Boersma W Van Der Werf T Changes of computed tomography features of bronchiectasis during one year of azithromycin treatment European respiratory journal. Conference: european respiratory society annual congress 2016. United kingdom 2016","DOI":"10.1183\/13993003.congress-2016.OA278"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0256|cit256","doi-asserted-by":"crossref","unstructured":"Barker AF O'Donnell AE Flume P Thompson PJ Ruzi JD de Gracia J Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials The Lancet. Respiratory medicine 2014 738 49","DOI":"10.1016\/S2213-2600(14)70165-1"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0257|cit257","unstructured":"Burr L Rogers G Taylor S Mcguckin M Serisier D Sub inhibitory erythromycin reduces the expression of key p. aeruginosa virulence determinants in non-CF bronchiectasis subjects Respirology (Carlton, Vic.) 2015 29 [TO 043]"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0258|cit258","doi-asserted-by":"crossref","unstructured":"Burr LD Rogers GB Chen AC Hamilton BR Pool GF Taylor SL Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-CF Bronchiectasis: an Analysis from the BLESS Trial Annals of the american thoracic society 2016 1697 703","DOI":"10.1513\/AnnalsATS.201601-044OC"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0259|cit259","doi-asserted-by":"crossref","unstructured":"Chalmers JD Smith MP McHugh BJ Doherty C Govan JR Hill AT Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis American journal of respiratory and critical care medicine 2012 657 65","DOI":"10.1164\/rccm.201203-0487OC"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0260|cit260","first-page":"53","article-title":"Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial","volume":"14","author":"Chang","year":"2013","journal-title":"BioMed Central"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0261|cit261","unstructured":"Chen A Martin M Lourie R Burr L Hasnain S Bowler S Clinical benefits of long-term, low-dose erythromycin in bronchiectasis are not due to modulation of sputum mucin content [Abstract] Respirology (Carlton, Vic.) 2014 88 [TP 093]"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0262|cit262","doi-asserted-by":"crossref","unstructured":"De Soyza A Aksamit TR Bandel T-J Criollo M Elborn J S Krahn U RESPIRE 1: ciprofloxacin DPI 32.5mg b.d. administered 14 day on\/off or 28 day on\/off vs placebo for 48 weeks in subjects with non-cystic fibrosis bronchiectasis (NCFB) European respiratory journal 2016 OA272","DOI":"10.1183\/13993003.congress-2016.OA272"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0263|cit263","unstructured":"Dimakou K Triantafillidou C Tsikritsaki K Gousiou A Dervas A Toumbis M Non CF bronchiectasis: The effect of inhaled antibiotics (tobramycin and colistin) in patients with pseudomonas aeruginosa [Abstract] European respiratory journal 2014 P244"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0264|cit264","doi-asserted-by":"crossref","unstructured":"Hare KM Grimwood K Chang AB Chatfield MD Valery PC Leach AJ Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo European journal of clinical microbiology & infectious diseases 2015 2275 85","DOI":"10.1007\/s10096-015-2480-0"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0265|cit265","unstructured":"Haworth C Bilton D Kenyon R Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonised by Pseudomonas aeruginosa [Abstract] European Respiratory Society 23rd Annual Congress; 2013 Sep 7-11; Barcelona 2013 577s [P2732]"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0266|cit266","unstructured":"Haworth C Bilton D Kenyon R Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonised by pseudomonas aeruginosa [Abstract] 2013 577s [P2732]"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0267|cit267","doi-asserted-by":"crossref","unstructured":"Haworth CS Foweraker JE Wilkinson P Kenyon RF Bilton D Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection American journal of respiratory and critical care medicine 2014 975 82","DOI":"10.1164\/rccm.201312-2208OC"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0268|cit268","unstructured":"Juthong S Eiamsa-ard S The effects of roxithromycin as anti-inflammatory agent on clinical outcomes in patient with bronchiectasis: a double blinded randomized controlled study European Respiratory Society 21st Annual Congress; 2011 Sep 24-28; Amsterdam 2011 819s [4496]"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0269|cit269","doi-asserted-by":"crossref","unstructured":"Kobbernagel HE Buchvald FF Haarman EG Casaulta C Collins SA Hogg C Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia BMC pulmonary medicine 2016 104","DOI":"10.1186\/s12890-016-0261-x"},{"issue":"11","key":"10.1002\/14651858.CD001392.pub3-BIB0270|cit270","first-page":"824","article-title":"Impact of treatment with low dose roxithromycin on stable","volume":"35","author":"Liu","year":"2012","journal-title":"Zhonghua jie he he hu xi za zhi [Chinese journal of tuberculosis and respiratory diseases]"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0271|cit271","doi-asserted-by":"crossref","unstructured":"Liu J Zhong X He Z Wei L Zheng X Zhang J Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasis Mediators of inflammation 2014 708608","DOI":"10.1155\/2014\/708608"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0272|cit272","doi-asserted-by":"crossref","unstructured":"Lourdesamy Anthony AI Muthukumaru U Efficacy of azithromycin in the treatment of bronchiectasis Respirology (Carlton, Vic.) 2014 1178 82","DOI":"10.1111\/resp.12375"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0273|cit273","unstructured":"Corrections to The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fi brosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial Lancet respiratory medicine 2015 e15"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0274|cit274","doi-asserted-by":"crossref","unstructured":"O'Donnell AE Bilton D Serisier D Wanner A Froehlich J Bruinenberg P ORBIT-3 and ORBIT-4: design of a Phase 3 Program to Investigate Safety and Efficacy of Pulmaquin in Non-Cystic Fibrosis Bronchiectasis (NCFBE) Patients Chronically Colonized with Pseudomonas Aeruginosa (PA) American journal of respiratory and critical care medicine 2016 A1775","DOI":"10.1055\/s-0036-1592235"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0275|cit275","doi-asserted-by":"crossref","unstructured":"O'Donnell A Bilton D Serisier D Wanner A Froehlich J Bruinenberg P A phase 3 study design of Pulmaquin in non-cystic fibrosis bronchiectasis (NCFBE) patients chronically colonized with pseudomonas aeruginosa (PA) Pneumologie. Conference: 1st world bronchiectasis conference. Germany. Conference start: 20160707. Conference end: 20160709 2016","DOI":"10.1055\/s-0036-1592235"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0276|cit276","doi-asserted-by":"crossref","unstructured":"Orriols R Hernando R Ferrer A Terradas S Montoro B Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis Respiration; international review of thoracic diseases 2015 299 305","DOI":"10.1159\/000438490"},{"key":"#cr-split#-10.1002\/14651858.CD001392.pub3-BIB0277|cit277.1","unstructured":"Rogers GB Bruce KD Martin ML Burr LD Serisier DJ The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.[Erratum appears in Lancet Respir Med. 2015 Apr;3(4): e15"},{"key":"#cr-split#-10.1002\/14651858.CD001392.pub3-BIB0277|cit277.2","unstructured":"PMID: 25890660] The Lancet. Respiratory medicine 2014 988 96"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD001392.pub3-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"431A","DOI":"10.1378\/chest.1793868","article-title":"Inhaled colistin in elderly patients with non-cystic fibrosis","volume":"145","author":"Tabernero","year":"2014","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.regg.2014.09.005","article-title":"Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection]. [Spanish","volume":"50","author":"Tabernero Huguet","year":"2015","journal-title":"Revista espanola de geriatria y gerontologia"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0280|cit280","doi-asserted-by":"crossref","unstructured":"Terpstra L Altenburg J Boersma W Effects of long term tobramycin inhalation solution (TIS) once daiLy on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. A doubleblind, randomized, placebo controlled trial. The BATTLE study Pneumologie. Conference: 1st world bronchiectasis conference. Germany. Conference start: 20160707. Conference end: 20160709 2016","DOI":"10.1055\/s-0036-1592239"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0281|cit281","unstructured":"Twiss J Byrnes C Nebulized antibiotics reduce symptoms, bacterial density and oral antibiotic usage in children with non-cystic fibrosis bronchiectasis 2009 Thoracic Society of Australia & New Zealand (TSANZ) and Australian & New Zealand Society of Respiratory Science (ANZSRS) Annual Scientific Meeting; 2009 3-8 April; Darwin Darwin, Australia 2009 A76"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0282|cit282","unstructured":"Twiss J Byrnes CA Nebulized antibiotics reduce symptoms, bacterial density and oral antibiotic usage in children with non-cystic fibrosis bronchiectasis American Thoracic Society International Conference; 2008 May 16-21; Toronto Toronto 2008 A681 [#C40]"},{"issue":"1","key":"10.1002\/14651858.CD001392.pub3-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2710.2006.00708.x","article-title":"Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis","volume":"31","author":"Yalcin","year":"2006","journal-title":"Journal of clinical pharmacy and therapeutics"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0284|cit284","unstructured":"Australian Institute of Health and Welfare Asthma, chronic obstructive pulmonary disease and other respiratory diseases in Australia http:\/\/www.aihw.gov.au\/WorkArea\/DownloadAsset.aspx?id=6442453795"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.164.9.2105083","article-title":"Bronchial inflammation and colonization in patients with clinically stable bronchiectasis","volume":"164","author":"Angrill","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD001392.pub3-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The Bronchiectasis Severity Index. An international derivation and validation study","volume":"189","author":"Chalmers","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5694\/j.1326-5377.2002.tb04733.x","article-title":"Bronchiectasis in indigenous children in remote Australian communities","volume":"177","author":"Chang","year":"2002","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0289|cit289","first-page":"6","article-title":"Inflammation: a two-edged sword-the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"European Journal of Respiratory Diseases Supplement"},{"issue":"8","key":"10.1002\/14651858.CD001392.pub3-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ppul.20646","article-title":"The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation","volume":"42","author":"Downey","year":"2007","journal-title":"Pediatric Pulmonology"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.rmed.2013.12.015","article-title":"Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis","volume":"108","author":"Goeminne","year":"2014","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.prrv.2010.10.009","article-title":"Airway microbiology and host defences in paediatric non-CF bronchiectasis","volume":"12","author":"Grimwood","year":"2011","journal-title":"Paediatric Respiratory Reviews"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9343(00)00507-6","article-title":"Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis","volume":"109","author":"Hill","year":"2000","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/COPD.S6133","article-title":"The pathophysiology of bronchiectasis","volume":"4","author":"King","year":"2009","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1620\/tjem.222.237","article-title":"High prevalence of bronchiectasis in adults: analysis of CT findings in a health screening program","volume":"222","author":"Kwak","year":"2010","journal-title":"The Tohoku Journal of Experimental Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0297|cit297","doi-asserted-by":"crossref","first-page":"459A","DOI":"10.1378\/chest.1119877","article-title":"The clinical characteristics of patients with non-CF bronchiectasis","volume":"140","author":"Lee","year":"2011","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0298|cit298","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1183\/09031936.00003709","article-title":"Mortality in bronchiectasis: a long-term study assessing the factors influencing survival","volume":"34","author":"Loebinger","year":"2009","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0299|cit299","first-page":"842","article-title":"Bronchiectasis: a guide for primary care","volume":"41","author":"Maguire","year":"2012","journal-title":"Australian Family Physician"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score","volume":"43","author":"Martinez-Garcia","year":"2014","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0301|cit301","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.arbr.2011.06.003","article-title":"Treatment of non-cystic fibrosis bronchiectasis","volume":"47","author":"Mart\u00ednez Garc\u00eda","year":"2011","journal-title":"Archivos de Bronconeumologia"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","article-title":"Non-cystic fibrosis bronchiectasis","volume":"188","author":"McShane","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1378\/chest.08-0776","article-title":"Bronchiectasis","volume":"134","author":"O'Donnell","year":"2008","journal-title":"Chest"},{"issue":"12","key":"10.1002\/14651858.CD001392.pub3-BIB0304|cit304","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1164\/rccm.200306-731OC","article-title":"Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis","volume":"168","author":"Ordonez","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0305|cit305","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/thx.5.3.233","article-title":"Reduction in bronchial subdivision in bronchiectasis","volume":"5","author":"Reid","year":"1950","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1164\/ajrccm.164.8.2104075","article-title":"Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction","volume":"164","author":"Sagel","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0308|cit308","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1183\/09031936.00226913","article-title":"How to assess the severity of bronchiectasis","volume":"45","author":"Saleh","year":"2014","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0309|cit309","first-page":"235","article-title":"Evaluation of the incidence and age distribution of bronchiectasis from the Finnish hospital discharge register","volume":"6","author":"Saynajakangas","year":"1998","journal-title":"Central European Journal of Public Health"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0310|cit310","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1378\/chest.11-2209","article-title":"Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000 to 2007","volume":"142","author":"Seitz","year":"2012","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2213-2600(13)70038-9","article-title":"Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases","volume":"1","author":"Serisier","year":"2013","journal-title":"Lancet Respiratory Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0312|cit312","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/resp.12247","article-title":"The evidence base for non-CF bronchiectasis is finally evolving","volume":"19","author":"Serisier","year":"2014","journal-title":"Respirology"},{"issue":"10","key":"10.1002\/14651858.CD001392.pub3-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1164\/rccm.201210-1937OC","article-title":"Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation","volume":"187","author":"Tunney","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0314|cit314","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/adc.2004.066472","article-title":"New Zealand national incidence of bronchiectasis \"too high\" for a developed country","volume":"90","author":"Twiss","year":"2005","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0315|cit315","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2431-12-122","article-title":"Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial","volume":"12","author":"Valery","year":"2012","journal-title":"BMC Paediatrics"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0316|cit316","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","article-title":"Prevalence and economic burden of bronchiectasis","volume":"12","author":"Weycker","year":"2005","journal-title":"Clinical Pulmonary Medicine"},{"key":"10.1002\/14651858.CD001392.pub3-BIB0317|cit317","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1183\/1025448x.10017912","article-title":"Definition and aetiology of non-CF bronchiectasis","volume-title":"The Spectrum of Bronchial Infection","author":"Wilson","year":"2013"},{"issue":"3","key":"10.1002\/14651858.CD001392.pub3-BIB0318|cit318","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/resp.12233","article-title":"Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis","volume":"19","author":"Wu","year":"2014","journal-title":"Respirology"},{"issue":"4","key":"10.1002\/14651858.CD001392.pub3-BIB0319|cit319","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001392","article-title":"Prolonged antibiotics for purulent bronchiectasis","author":"Evans","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001392.pub3-BIB0320|cit320","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001392.pub2","article-title":"Prolonged antibiotics for purulent bronchiectasis in children and adults","author":"Evans","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001392.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:12:50Z","timestamp":1748563970000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001392.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,13]]},"references-count":321,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001392.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,13]]}}}